Non-vascular drug eluting stents as localized controlled drug delivery platform: Preclinical and clinical experience

Journal of Controlled Release

Volumn 172, Issue 1, 2013, Pages 105-117

  Shaikh, Mohsin ^a   Kichenadasse, Ganessan ^b   Choudhury, Namita Roy ^a   Butler, Ross ^a   Garg, Sanjay ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Clinical trials; Drug eluting stents; Non vascular stents; Preclinical studies

Indexed keywords

CLINICAL EXPERIENCE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG-ELUTING STENTS; PERCUTANEOUS CORONARY INTERVENTION; PRECLINICAL STUDIES; REGULATORY REQUIREMENTS; VASCULAR STENTS;

CONTROLLED DRUG DELIVERY;

STENTS;

CEFOTAXIME; CHROMIUM; COBALT; DEXAMETHASONE; ETHYLENE VINYL ACETATE COPOLYMER; FLUOROURACIL; GEMCITABINE; INDOMETACIN; KETOROLAC; LIDOCAINE; MITOMYCIN; MOMETASONE FUROATE; NICKEL; OXYBUTYNIN; PACLITAXEL; PLATINUM; POLITEF; POLOXAMER; POLYCAPROLACTONE; POLYDIOXANONE; POLYGLACTIN; POLYLACTIDE; POLYURETHAN; SILICONE; SIMVASTATIN; STAINLESS STEEL; TANTALUM; TITANIUM; TRIAMCINOLONE ACETONIDE; TRICLOSAN;

ADHESION; ANGIOGRAPHY; BIOCOMPATIBILITY; BIODEGRADATION; BRONCHIAL STENT; BRONCHOGRAPHY; BRONCHOSCOPE; CANCER PATIENT; CHOLANGITIS; CHOLESTASIS; CLINICAL TRIAL (TOPIC); COLONOSCOPE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY STENT; DEVICE INFECTION; DEVICE SAFETY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG RELEASE; DUODENUM OBSTRUCTION; ENDOSCOPIC SINUS SURGERY; ESOPHAGEAL ADENOCARCINOMA; ETHMOIDECTOMY; FORCED EXPIRATORY VOLUME; HEALTH CARE QUALITY; HUMAN; IMMUNE RESPONSE; LUNG TRANSPLANTATION; MARKETING; MAXILLARY SINUS; METAL STENT; MULTICENTER STUDY (TOPIC); NITINOL STENT; NONHUMAN; NONVASCULAR STENT; NOSE POLYP; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PANCREAS ADENOCARCINOMA; PANCREATITIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS; RESTENOSIS; REVIEW; SELF EXPANDING STENT; SINUSITIS; STENT; STOMACH CARCINOMA; SYSTEMIC THERAPY; TARGET ORGAN; THROMBOSIS; TRACHEA STENOSIS; URETER STENT; URETHRAL STENT; UROGRAPHY; UROLOGIC STENT; WOUND HEALING;

CLINICAL TRIALS; DRUG ELUTING STENTS; NON-VASCULAR STENTS; PRECLINICAL STUDIES;

ANIMALS; CLINICAL TRIALS AS TOPIC; DEVICE APPROVAL; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; HUMANS;

EID: 84883513142     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.08.010     Document Type: Review

References (90)

1. L. Machan Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagus Adv. Drug Deliv. Rev. 58 2006 447 462 (Pubitemid 43816742)
2. US-FDA Combination Product Definition 2013 FDA
3. D.S. Couto, L. Perez-Breva, P. Saraiva, and C.L. Cooney Lessons from innovation in drug-device combination products Adv. Drug Deliv. Rev. 64 2012 69 77
4. M. Dickson, and J.P. Gagnon Key factors in the rising cost of new drug discovery and development Nat. Rev. Drug Discov. 3 2004 417 429 (Pubitemid 38618124)
5. J.A. DiMasi, R.W. Hansen, and H.G. Grabowski The price of innovation: new estimates of drug development costs J. Health Econ. 22 2003 151 185 (Pubitemid 36279392)
6. M.A. Hupcey, and S. Ekins Improving the drug selection and development process for combination devices Drug Discov. Today 12 2007 844 852 (Pubitemid 47539964)
7. Drug-Device Combination Market Worth US$18.54 Billion by 2014 PR Newswire Europe Including UK Disclose 2009 (n/a)
8. H.M. Burt, and W.L. Hunter Drug-eluting stents: a multidisciplinary success story Adv. Drug Deliv. Rev. 58 2006 350 357 (Pubitemid 43816738)
9. W. Khan, S. Farah, and A.J. Domb Drug eluting stents: developments and current status J. Control. Release 161 2012 703 712
10. D.J. Pisano, and D.S. Mantus FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics 2008 Informa Healthcare USA
11. B.V. Sweet, A.K. Schwemm, and D.M. Parsons Review of the processes for FDA oversight of drugs, medical devices, and combination products J. Manag. Care Pharm. 17 2011 40 50
12. FDA Guidance for Industry: Coronary Drug-eluting Stents-Nonclinical and Clinical Studies CDRH 2008
13. FDA Summary of Premarket Approval Application: PROPEL Stent FDA 2011
14. The Drug-eluting Stent Market Outlook to 2016 Market Sizes, Dynamics, and Growth Forecasts; Innovations; and Assessment of Leading and Emerging Players March 2011
15. A.V. Kaplan, and D.O. Williams Medical device regulatory landscape: the imperative of finding balance Circ. Cardiovasc. Interv. 5 2012 2 5
16. P.J. Catalano, M. Thong, R. Weiss, and T. Rimash The MicroFlow spacer: a drug-eluting stent for the ethmoid sinus Indian J. Otolaryngol. Head Neck Surg. 63 2011 279 284
17. C. Bakal, and J. Silberzweig Vascular and Interventional Radiology: Principles and Practice 2002 Thieme
18. S. Kadir Teaching Atlas of Interventional Radiology: Non-vascular Interventional Procedures 2006 Thieme
19. K.W. Lau, K.H. Mak, J.S. Hung, and U. Sigwart Clinical impact of stent construction and design in percutaneous coronary intervention Am. Heart J. 147 2004 764 773 (Pubitemid 38880980)
20. J.C. Martinez, M.M. Puc, and R.M. Quiros Esophageal stenting in the setting of malignancy ISRN Gastroenterol. 2011 2011 719575
21. B.W. Bang, S. Jeong, D.H. Lee, J.I. Lee, S.C. Lee, and S.G. Kang The biodurability of covering materials for metallic stents in a bile flow phantom Dig. Dis. Sci. 57 2012 1056 1063
22. M. Zilberman, K.D. Nelson, and R.C. Eberhart Mechanical properties and in vitro degradation of bioresorbable fibers and expandable fiber-based stents J. Biomed. Mater. Res. B Appl. Biomater. 74 2005 792 799 (Pubitemid 41076951)
23. M. Zilberman, and R.C. Eberhart Drug-eluting bioresorbable stents for various applications Annu. Rev. Biomed. Eng. 8 2006 153 180 (Pubitemid 44314815)
24. J.B. Wolinsky, Y.L. Colson, and M.W. Grinstaff Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers J. Control. Release 159 2012 14 26
25. P. Wu, and D.W. Grainger Drug/device combinations for local drug therapies and infection prophylaxis Biomaterials 27 2006 2450 2467 (Pubitemid 41821824)
26. S. Moon, S.G. Yang, and K. Na An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis Biomaterials 32 2011 3603 3610
27. M.J. Chung, H. Kim, K.S. Kim, S. Park, J.B. Chung, and S.W. Park Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model J. Gastroenterol. Hepatol. 27 2012 261 267
28. J.H. Shin, H.Y. Song, T.S. Seo, S.H. Yuk, Y.H. Kim, Y.M. Cho, G.B. Choi, T.H. Kim, and J.Y. Suh Influence of a dexamethasone-eluting covered stent on tissue reaction: an experimental study in a canine bronchial model Eur. Radiol. 15 2005 1241 1249 (Pubitemid 40778749)
29. B.W. Herrmann, M.J. Citardi, G. Vogler, L. Gardner, G. Smith, A.R. Javer, H.M. Burt, J. Jackson, and F.A. Kuhn A preliminary report on the effects of paclitaxel-impregnated stents on sheep nasal mucosa Am. J. Rhinol. 18 2004 119 124 (Pubitemid 38714313)
30. G.H. Zhu, A.H. Ng, S.S. Venkatraman, F.Y. Boey, A.L. Wee, S.L. Trasti, and L.H. Yee Lim A novel bioabsorbable drug-eluting tracheal stent Laryngoscope 121 2011 2234 2239
31. C.K. Choong, L. Phan, P. Massetti, F.J. Haddad, C. Martinez, E. Roschak, and J.D. Cooper Prolongation of patency of airway bypass stents with use of drug-eluting stents J. Thorac. Cardiovasc. Surg. 131 2006 60 64 (Pubitemid 43049784)
32. A.G. Beule, C. Scharf, K.E. Biebler, A. Gopferich, E. Steinmeier, E. Wolf, W. Hosemann, and H. Kaftan Effects of topically applied dexamethasone on mucosal wound healing using a drug-releasing stent Laryngoscope 118 2008 2073 2077
33. P.M. Li, D. Downie, and P.H. Hwang Controlled steroid delivery via bioabsorbable stent: safety and performance in a rabbit model Am. J. Rhinol. Allergy 23 2009 591 596
34. D.W. Kennedy The PROPEL steroid-releasing bioabsorbable implant to improve outcomes of sinus surgery Expert Rev. Respir. Med. 6 2012 493 498
35. P.M. Baptista, J. de Abajo, S. Fernandez, and L. Barona Stratus relieva: treatment for chronic rhinosinusitis Otolaryngol. Head Neck 147 2012 P255 P256
36. B.H. Chew, H. Davoudi, J. Li, and J.D. Denstedt An in vivo porcine evaluation of the safety, bioavailability, and tissue penetration of a ketorolac drug-eluting ureteral stent designed to improve comfort J. Endourol. 24 2010 1023 1029
37. J.H. Shin, H.Y. Song, C.G. Choi, S.H. Yuk, J.S. Kim, Y.M. Kim, C.J. Yoon, T.H. Kim, J.Y. Suh, and X. He Tissue hyperplasia: influence of a paclitaxel-eluting covered stent-preliminary study in a canine urethral model Radiology 234 2005 438 444 (Pubitemid 40139914)
38. L. Machan, H.M. Burt, and W.L. Hunter Local delivery of chemotherapy: a supplement to existing cancer treatments. A case for surgical pastes and coated stents Adv. Drug Deliv. Rev. 26 1997 199 207 (Pubitemid 27289534)
39. J. Aoki, A.T. Ong, A. Abizaid, P. den Heijer, H. Bonnier, D.R. McClean, S. Verheye, J. Belardi, J.A. Condado, M. Pieper, J.E. Sousa, M. Bressers, J. Symons, F. Litvack, G. Sianos, and P.W. Serruys One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES) EuroIntervention 1 2005 165 172
40. M.I. Papafaklis, Y.S. Chatzizisis, K.K. Naka, G.D. Giannoglou, and L.K. Michalis Drug-eluting stent restenosis: effect of drug type, release kinetics, hemodynamics and coating strategy Pharmacol. Ther. 134 2012 43 53
41. K. Katsanos, T. Sabharwal, and A. Adam Stenting of the upper gastrointestinal tract: current status Cardiovasc. Intervent. Radiol. 33 2010 690 705
42. M. Pavlides, and D.A. Gorard Stents in Gastrointestinal Endoscopy Therapeutic Gastrointestinal Endoscopy InTech 2011
43. Y. Zhang, J. Shi, B. Shi, C.Y. Song, W.F. Xie, and Y.X. Chen Self-expanding metallic stent as a bridge to surgery versus emergency surgery for obstructive colorectal cancer: a meta-analysis Surg. Endosc. 26 2012 110 119
44. M. Kalinowski, H. Alfke, B. Kleb, F. Durfeld, and H. Joachim Wagner Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: possible topical application in malignant bile duct obstructions Invest. Radiol. 37 2002 399 404 (Pubitemid 34680202)
45. J.W. Lee, S.G. Yang, and K. Na Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer Int. J. Pharm. 427 2012 276 283
46. S.R. Guo, Z.M. Wang, Y.Q. Zhang, L. Lei, J.M. Shi, K.M. Chen, and Z. Yu In vivo evaluation of 5-fluorouracil-containing self-expandable nitinol stent in rabbits: efficiency in long-term local drug delivery J. Pharm. Sci. 99 2010 3009 3018
47. D.K. Lee, H.S. Kim, K.S. Kim, W.J. Lee, H.K. Kim, Y.H. Won, Y.R. Byun, M.Y. Kim, S.K. Baik, and S.O. Kwon The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane Gastrointest. Endosc. 61 2005 296 301 (Pubitemid 40261091)
48. S.I. Jang, J.H. Kim, M. Kim, S. Yang, E.A. Jo, J.W. Lee, K. Na, J.M. Kim, S. Jeong, D.H. Lee, and D.K. Lee Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane Endoscopy 44 2012 825 831
49. S.S. Lee, J.H. Shin, J.M. Han, C.H. Cho, M.H. Kim, S.K. Lee, J.H. Kim, K.R. Kim, K.M. Shin, Y.H. Won, and H.Y. Song Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model Gastrointest. Endosc. 69 2009 1140 1147
50. S.R. Jeon, S.H. Eun, C.S. Shim, C.B. Ryu, J.O. Kim, J.Y. Cho, J.S. Lee, M.S. Lee, and S.Y. Jin Effect of drug-eluting metal stents in benign esophageal stricture: an in vivo animal study Endoscopy 41 2009 449 456
51. D.I. Gwon, S.S. Lee, and E.-Y. Kim Cefotaxime-eluting covered self-expandable stents in a canine biliary model: scanning electron microscopic study of biofilm formation Acta Radiol. 53 2012 1127 1132
52. K.T. Suk, J.W. Kim, H.S. Kim, S.K. Baik, S.J. Oh, S.J. Lee, H.G. Kim, D.H. Lee, Y.H. Won, and D.K. Lee Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study Gastrointest. Endosc. 66 2007 798 803 (Pubitemid 47495917)
53. S.I. Jang, J.H. Kim, J.W. You, K. Rhee, S.J. Lee, H.G. Kim, J. Han, I.H. Shin, S.H. Park, and D.K. Lee Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study Dig. Dis. Sci. 58 2013 865 871
54. D.K. Manifold, N.D. Maynard, M. Cowling, L. Machan, R.C. Mason, and A. Adam Taxol coated stents in oesophageal adenocarcinoma Gastroenterology 114 1998 A27
55. T.J. Song, S.S. Lee, S.C. Yun, H. Park do, D.W. Seo, S.K. Lee, and M.H. Kim Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study Gastrointest. Endosc. 73 2011 727 733
56. W. Hosemann, M.E. Wigand, U. Gode, F. Langer, and I. Dunker Normal wound healing of the paranasal sinuses: clinical and experimental investigations Eur. Arch. Otorhinolaryngol. 248 1991 390 394
57. A.G. Beule, E. Steinmeier, H. Kaftan, K.E. Biebler, A. Gopferich, E. Wolf, and W. Hosemann Effects of a dexamethasone-releasing stent on osteoneogenesis in a rabbit model Am. J. Rhinol. Allergy 23 2009 433 436
58. B.S. Bleier, D.P. Paulson, B.W. O'Malley, D. Li, J.N. Palmer, A.G. Chiu, and N.A. Cohen Chitosan glycerophosphate-based semirigid dexamethasone eluting biodegradable stent Am. J. Rhinol. Allergy 23 2009 76 79
59. A.H. Murr, T.L. Smith, P.H. Hwang, N. Bhattacharyya, B.J. Lanier, J.W. Stambaugh, and A.S. Mugglin Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent Int. Forum Allergy Rhinol. 1 2011 23 32
60. K.D. Forwith, R.K. Chandra, P.T. Yun, S.K. Miller, and H.D. Jampel ADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants Laryngoscope 121 2011 2473 2480
61. B.F. Marple, T.L. Smith, J.K. Han, A.R. Gould, H.D. Jampel, J.W. Stambaugh, and A.S. Mugglin Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants Otolaryngol. Head Neck Surg. 146 2012 1004 1011
62. P.M. Baptista, J. de Abajo, and L. Barona Relieva Stratus®, Treatment for Chronic Rhinosinusitis, in: AAO-HNSF Annual Meeting and OTO EXPO 2012 American Academy of Otolaryngology-Head and Neck Surgery Foundation Washington, DC
63. W. Huvenne, N. Zhang, E. Tijsma, B. Hissong, J. Huurdeman, G. Holtappels, S. Claeys, P. Van Cauwenberge, H. Nelis, T. Coenye, and C. Bachert Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery Wound Repair Regen. 16 2008 757 767
64. K.Y. Detwiller, T.L. Smith, J.C. Mace, D.R. Trune, and N.B. Sautter Steroid-independent upregulation of matrix metalloproteinase 9 in chronic rhinosinusitis patients with radiographic evidence of osteitis Int Forum Allergy Rhinol. 3 2013 364 368
65. Y.K. Chao, K.S. Liu, Y.C. Wang, Y.L. Huang, and S.J. Liu Biodegradable Cisplatin-eluting tracheal stent for malignant airway obstruction: in vivo and in vitro studies Chest 144 2013 193 199
66. R.F. Ward, and M.M. April Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction Int. J. Pediatr. Otorhinolaryngol. 44 1998 221 226 (Pubitemid 28417293)
67. P.F. Cardoso, G.I. Snell, P. Hopkins, G.W. Sybrecht, G. Stamatis, A.W. Ng, and P. Eng Clinical application of airway bypass with paclitaxel-eluting stents: early results J. Thorac. Cardiovasc. Surg. 134 2007 974 981 (Pubitemid 47454624)
68. H.F. Lausberg, K. Chino, G.A. Patterson, B.F. Meyers, P.D. Toeniskoetter, and J.D. Cooper Bronchial fenestration improves expiratory flow in emphysematous human lungs Ann. Thorac. Surg. 75 2003 393 397
69. discussion 398.
70. P.L. Shah, D.J. Slebos, P.F. Cardoso, E.J. Cetti, G.W. Sybrecht, and J.D. Cooper Design of the exhale airway stents for emphysema (EASE) trial: an endoscopic procedure for reducing hyperinflation BMC Pulm. Med. 11 2011 1
71. C.K. Choong, F.J. Haddad, E.Y. Gee, and J.D. Cooper Feasibility and safety of airway bypass stent placement and influence of topical mitomycin C on stent patency J. Thorac. Cardiovasc. Surg. 129 2005 632 638 (Pubitemid 40311324)
72. P.L. Shah, D.J. Slebos, P.F. Cardoso, E. Cetti, K. Voelker, B. Levine, M.E. Russell, J. Goldin, M. Brown, J.D. Cooper, and G.W. Sybrecht Bronchoscopic lung-volume reduction with exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial Lancet 378 2011 997 1005
73. B.H. Chew, M. Duvdevani, and J.D. Denstedt New developments in ureteral stent design, materials and coatings Expert Rev. Med. Devices 3 2006 395 403
74. D. Lange, and B.H. Chew Update on ureteral stent technology Ther. Adv. Urol. 1 2009 143 148
75. B.H. Chew, P.A. Cadieux, G. Reid, and J.D. Denstedt In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens J. Endourol. 20 2006 949 958 (Pubitemid 44907031)
76. D. Lange, C.N. Elwood, K. Choi, K. Hendlin, M. Monga, and B.H. Chew Uropathogen interaction with the surface of urological stents using different surface properties J. Urol. 182 2009 1194 1200
77. P.A. Cadieux, B.H. Chew, B.E. Knudsen, K. Dejong, E. Rowe, G. Reid, and J.D. Denstedt Triclosan loaded ureteral stents decrease Proteus mirabilis 296 infection in a rabbit urinary tract infection model J. Urol. 175 2006 2331 2335 (Pubitemid 43668543)
78. D.T. Beiko, J.D. Watterson, B.E. Knudsen, L. Nott, S.E. Pautler, G.B. Brock, H. Razvi, and J.D. Denstedt Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy J. Endourol. 18 2004 723 730 (Pubitemid 39441760)
79. E.N. Liatsikos, D. Karnabatidis, G.C. Kagadis, K. Rokkas, C. Constantinides, N. Christeas, N. Flaris, T. Voudoukis, C.D. Scopa, P. Perimenis, K.S. Filos, G.C. Nikiforidis, J.U. Stolzenburg, and D. Siablis Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study Eur. Urol. 51 2007 217 223 (Pubitemid 44821516)
80. P. Kallidonis, P. Kitrou, D. Karnabatidis, I. Kyriazis, C. Kalogeropoulou, A. Tsamandas, D.J. Apostolopoulos, T. Vrettos, D. Liourdi, S. Spiliopoulos, A. Al-Aown, C.D. Scopa, and E. Liatsikos Evaluation of zotarolimus-eluting metal stent in animal ureters J. Endourol. 25 2011 1661 1667
81. P.A. Cadieux, B.H. Chew, L. Nott, S. Seney, C.N. Elwood, G.R. Wignall, L.W. Goneau, and J.D. Denstedt Use of triclosan-eluting ureteral stents in patients with long-term stents J. Endourol. 23 2009 1187 1194
82. C.E. Mendez-Probst, L.W. Goneau, K.W. MacDonald, L. Nott, S. Seney, C.N. Elwood, D. Lange, B.H. Chew, J.D. Denstedt, and P.A. Cadieux The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial BJU Int. 110 2012 749 754
83. A.E. Krambeck, R.S. Walsh, J.D. Denstedt, G.M. Preminger, J. Li, J.C. Evans, and J.E. Lingeman A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent J. Urol. 183 2010 1037 1042
84. A. Kotsar, R. Nieminen, T. Isotalo, J. Mikkonen, I. Uurto, M. Kellomaki, M. Talja, E. Moilanen, and T.L. Tammela Preclinical evaluation of new indomethacin-eluting biodegradable urethral stent J. Endourol. 26 2012 387 392
85. T.L. Tammela, and M. Talja Biodegradable urethral stents BJU Int. 92 2003 843 850 (Pubitemid 37475950)
86. A. Kotsar, T. Isotalo, I. Uurto, J. Mikkonen, P. Martikainen, M. Talja, M. Kellomaki, J.P. Salenius, and T.L. Tammela Urethral in situ biocompatibility of new drug-eluting biodegradable stents: an experimental study in the rabbit BJU Int. 103 2009 1132 1135
87. A. Kotsar, R. Nieminen, T. Isotalo, J. Mikkonen, I. Uurto, M. Kellomaki, M. Talja, E. Moilanen, and T.L. Tammela Biocompatibility of new drug-eluting biodegradable urethral stent materials Urology 75 2010 229 234
88. T. Shah Drug-eluting stents in malignant biliary obstruction: where do we stand? Dig Dis Sci 58 2013 610 612
89. A. Al-Aown, I. Kyriazis, P. Kallidonis, P. Kraniotis, C. Rigopoulos, D. Karnabatidis, T. Petsas, and E. Liatsikos Ureteral stents: new ideas, new designs Ther. Adv. Urol. 2 2010 85 92
90. W. Hosemann, E. Schindler, E. Wiegrebe, and A. Gopferich Innovative frontal sinus stent acting as a local drug-releasing system Eur Arch Otorhinolaryngol 260 2003 131 134 (Pubitemid 36437749)